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To investigate if children who later developed acute lymphoblastic leukaemia (ALL) were prenatally infected with human herpes virus
6 (HHV-6) and/or Epstein–Barr virus (EBV), Guthrie cards taken at birth were analysed by PCR. Guthrie cards from 54 patients with
ALL and 47 healthy controls matched for age and birth place were tested negative for both HHV-6 and EBV DNA. All samples
contained amplifiable DNA when tested by HLA-DQ PCR. Our negative findings suggest that childhood ALL is unlikely to be
associated with an in utero infection with EBV or HHV-6.
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Acute lymphoblastic leukaemia (ALL) is the most frequent
childhood malignancy in Western countries. The different
subtypes of leukaemia differ in their patterns of genetic change,
natural history, prognosis and possibly aetiology (Doll, 1989; Ross,
1999). One model for the aetiology of childhood ALL is prenatal
infection and such a maternal infection could affect foetal
haematopoiesis early in the liver and later in the bone marrow
(Ohls and Christensen, 2000).The relevant agent would have to
cross the placenta, induce genomic instability in the lymphocytes
and infect the foetus without causing severe foetal abnormalities
(Smith, 1997). We have analysed human polyomaviruses (JCV and
BKV) and human parvovirus B19 in Guthrie cards from children
who later developed ALL, but could detect neither polyomavirus
DNA nor parvovirus DNA from ALL cases or controls (Priftakis
et al, 2003; Isa et al, 2004).
Epstein–Barr virus (EBV) and human herpes virus 6 (HHV-6)
are two potentially oncogenic viruses widely distributed in the
human population, which can be spread by vertical or horizontal
(in utero) transmission. Since they persist and establish latency in
their natural host after primary infection, they may be reactivated
during immunosuppression (Matsuda et al, 1999). The viral
latency is primarily established in lymphocytes, which may be
important in relation to childhood ALL (Gustafsson et al, 2000;
Salonen et al, 2002).
Our study was conducted to determine if a group of children
with ALL were prenatally infected with HHV-6 or EBV. Guthrie




We collected Guthrie cards from 54 children who had developed
ALL. A total of 50 of these children had been diagnosed as pre-B
ALL (either CD10þ, CD20þ, FAB L1 or L2) and four children
were diagnosed as T-ALLs (CD3þ or CD8þ). In all, 24 children
were diagnosed before the age of 4, 16 children were between 5 and
9 years, 12 children were between 10 and 14 years of age and two
children were older than 14 years. The median age at diagnosis was
5 years (range 9 months–17 years, mean 5.9 years). These children
had been admitted for treatment at four different Paediatric
Oncology Swedish Centres from 1980 through 2001. As a control
group, we obtained 47 healthy controls that were matched for age
and birthplace, and data from the controls were collected from the
Swedish Medical Birth Register, which is a standardised set of
medical records introduced in Sweden in 1973 (Cnattingius et al,
1990). The capillary blood from both groups was collected at 3–5
days of age. After the screening analysis, the Guthrie cards are
stored at 41C at the PKU laboratory, at Karolinska University
Hospital, Huddinge.
Two bone marrow-transplanted patients were positive for HHV-
6 and EBV DNA, respectively. These two patients were included as
positive controls. Guthrie cards ‘spiked’ with blood from these
patients were tested for the presence of HHV-6 or EBV DNA. Blood
samples were taken from these two patients and added to a new
Guthrie card.
Methods
DNA extraction by minimal essential medium (MEM) At the time
of analysis, the filter paper samples were stored at room
temperature before extraction. The extraction method utilised
was MEM extraction, previously described,with minor modifica- Received 24 March 2004; revised 19 May 2004; accepted 30 June 2004
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ytions (Barbi et al, 1996). Three uniform discs, 3mm in diameter,
were removed from the filter paper, and prepared using special
precautions in order to avoid contamination, as described
previously.
Human herpes virus 6 DNA detection Presence of HHV-6 DNA
was analysed by a nested PCR, with the primers corresponding to
the conserved region of HHV-6 in both variants A and B,
amplifying a 173bp segment (Wang et al, 1996). Purified DNA
extracted from HHV-6 strain GS (type A) and strain Z29 (type B)
was used as positive controls in all PCRs. The sensitivity estimated
using known concentrations of positive controls’ DNA was 20–30
genomes/PCR reaction for both strains (Wang et al, 1996).
EBV DNA detection Presence of EBV DNA was analysed by a
nested PCR, with the primers corresponding to the fragment of
EBV EBNA gene 1 amplifying a 208bp segment (Cinque et al, 1993;
Wang et al, 1996).
HLA PCR As a control for the presence of DNA extracted from
Guthrie cards and for DNA amplifiability, a PCR with a set of HLA-
DQ primers was performed (Saiki et al, 1986). The HLA PCR-
negative samples were not used for further investigation.
Ethical considerations
Written informed consent was obtained from patients, controls
and parents. The local ethics committee of the Karolinska
Institutet at Karolinska University Hospital approved the study
protocol.
RESULTS AND DISCUSSION
The Guthrie cards of all 54 patients with ALL, as well as all 47
healthy controls, were tested negative by PCR for both HHV-6
DNA and EBV DNA. All samples contained amplifiable DNA when
tested by HLA-DQ PCR. Human herpes virus 6 or EBV DNA could
be detected in the blood as well as in the ‘spiked’ Guthrie cards
from the two BMT patients with HHV-6 and EBV infection,
respectively.
The use of stored Guthrie cards as a source of DNA has been
shown to have several uses. DNA is relatively stable and blood
collected from newborns contains 2–3 times higher levels of
nucleic acid when compared to adults. In several studies, it has
been shown that viral DNA could be successfully amplified from
Guthrie cards in case of congenital CMV, HSV and HIV infection
(Cassol et al, 1991; Barbi et al, 1996; Fischler et al, 1999).The
difficulty in dividing childhood leukaemia into homogenous
subgroups presents a problem for investigating different aetiolo-
gical factors. In our material, the majority of children had pre-B-
ALL. It has been suggested that infection in utero with a virus that
has the oncogenic potential could be involved in the initiation of
ALL, by inducing genomic instability in B lymphocytes. Twin
studies suggest that an additional molecular event or exposure is
then required postnatally for the preleukaemic clone to expand.
The second event, leading to leukaemia, can occur at a time of
maximum stress on lymphocyte precursor proliferation and may
be promoted by exposure to a common infectious agent (Greaves,
1999; Wiemels et al, 1999).
Space–time clustering of ALL has raised the possibility of an
infectious agent in ALL. Later, Kinlen and others proposed that the
mixing of previously separate urban and rural groups of people, as
in the creation of new towns in rural construction projects or
military camps, may raise the incidence of leukaemia by
facilitating transmission of infective agents (Kinlen et al, 1990;
Kinlen and Balkwill, 2001; Kinlen et al, 2002). Although most
reports have emphasised space–time clustering at diagnosis
(Petridou et al, 1996; Alexander et al, 1997; Gilman et al, 1999),
recent studies have detected space–time clustering around the
time of birth (Alexander, 1992; Gustafsson and Carstensen, 1999,
2000; Birch et al, 2000). While this may reflect exposures operating
in utero, the leukaemogenic infection may occur after birth since
addresses used in space–time clustering studies often apply well
after birth. Another model for virus transmission during
pregnancy is suggested by observations that leukaemia in cats
can result from maternal transmission (Knox et al, 1980).
Intrauterine infection is a result of either primary maternal
infection or reactivation of the latent infection. Primary infection
with HHV-6 during pregnancy is a rare event, since more than 90%
are seropositive at the age of 3, infection being most frequent
during the first year of life (Dahl et al, 1990, 1999; Hall et al, 1994).
Human herpes virus 6 reactivation may be more common than
primary infection in pregnancy and foetal transmission may occur
in about 1% of pregnancies (Dahl et al, 1999). Human herpes virus
6 was first isolated from cultures of the peripheral blood
lymphocytes of patients with AIDS and lymphoproliferative
diseases; it is considered to play an important role in the
development of complications after stem cell transplantation
(Salahuddin et al, 1986; Matsuda et al, 1999).
Epstein–Barr virus was first discovered through its close
relationship with the endemic form of Burkitt lymphoma, the
most common childhood cancer in equatorial Africa (Burkitt,
1958; Epstein et al, 1964). Epstein–Barr virus reactivation is also
frequent in organ and stem cell transplant patients in whom it can
produce lethal lymphoproliferative disease (Gustafsson et al,
2000). The experience of EBV in the transplant setting clearly
illustrates the ability of the EBV virus to reactivate the
immunosuppressant and its oncological potential. Besides the
transplant setting, EBV is also frequently reactivated during
pregnancy (Costa et al, 1985). The seroprevalence of EBV in
adults has been reported to be higher than 90% (Rickinson,
1996).In a recent study (Lehtinen et al, 2003), maternal reactiva-
tion of EBV infection (as shown by serum EBV IgM antibodies)
during the first trimester was associated with a significantly
increased risk of developing ALL in the offspring. As the specificity
of IgM is known to be imperfect in EBV reactivation, PCR analysis
was performed in addition. Of 77 IgM-positive women, there were
only two that were EBV DNA positive, compared to three cases of
EBV DNA-positive women in the control group, indicating that
viraemia was uncommon during reactivaton (Lehtinen et al, 2003).
The fact that neither HHV-6 DNA nor EBV were detected in
dried blood spots obtained from newborns at birth indicates that
congenital infections with these viruses are uncommon. The
possibility of false-negative results due to infection early in
pregnancy and being latent at birth must be considered. However,
for congenital CMV infection, it has been shown that Guthrie cards
were positive for CMV DNA even when the maternal infection took
place during the first or second trimester, indicating that viraemia
persisted to birth (Peckham, 1991). Similar findings were reported
in cases of intrauterine foetal death in association with parvovirus
B19 infection (Tolfvenstam et al, 2001).
Human herpes virus 6 DNA and EBV-DNA were detected by
PCR in the blood from Guthrie cards neither in children who had
developed ALL nor from healthy controls. Hence, it is unlikely that
childhood ALL is associated with an in utero infection with these
viruses, although a latent infection cannot be excluded by this
method, nor infection after birth. In view of the epidemiological
evidence for a relation between childhood ALL and infection, the
search for a virus aetiology must continue.
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